Using a murine chronic asthma model with genetically modified transgenic (TG) mice that constitutively overexpress IL-13 in the lung, the study aimed to evaluate the anti-asthmatic effects of human umbilical cord-derived MSCs (hUC-MSCs) primed with Liproxstatin-1. Here, IL13 is linked to chronic asthma.